Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Consolidated Statements Of Equity (Deficit)

v3.21.2
Condensed Consolidated Consolidated Statements Of Equity (Deficit) - USD ($)
$ in Thousands
Total
Bridge Notes
Retroactive application of the recapitalization
Previously Reported
Adoption of accounting standards
Adjusted balance
Common Stock warrants
 [1]
Common Stock warrants
Merger
Preferred Stock
Common Stock
Common Stock
Bridge Notes
Common Stock
Retroactive application of the recapitalization
Common Stock
Previously Reported
Common Stock
Adjusted balance
Common Stock
Common Stock warrants
 [1]
Common Stock
Common Stock warrants
Merger
Common Stock
Common Class A
Common Stock
Common Class A
Retroactive application of the recapitalization
Common Stock
Common Class A
Previously Reported
Common Stock
Common Class A
Adjusted balance
Common Stock
Common Class B
Common Stock
Common Class B
Retroactive application of the recapitalization
Common Stock
Common Class B
Previously Reported
Common Stock
Common Class B
Adjusted balance
Common Stock
Preferred Stock
Additional Paid-in Capital
Additional Paid-in Capital
Bridge Notes
Additional Paid-in Capital
Retroactive application of the recapitalization
Additional Paid-in Capital
Previously Reported
Additional Paid-in Capital
Adjusted balance
Additional Paid-in Capital
Common Stock warrants
 [1]
Additional Paid-in Capital
Common Stock warrants
Merger
Additional Paid-in Capital
Preferred Stock
Treasury Stock
Treasury Stock
Retroactive application of the recapitalization
Treasury Stock
Previously Reported
Treasury Stock
Adjusted balance
Accumulated Deficit
Accumulated Deficit
Retroactive application of the recapitalization
Accumulated Deficit
Previously Reported
Accumulated Deficit
Adoption of accounting standards
Accumulated Deficit
Adjusted balance
Beginning balance, Carrying amount at Dec. 31, 2019 $ 0   $ (171,321) $ 171,321   $ 0                                                                        
Beginning balance, Shares outstanding (in shares) at Dec. 31, 2019 0   (76,971,000) 76,971,000   0                                                                        
Ending balance, Carrying amount at Sep. 30, 2020 $ 0                                                                                  
Ending balance, Shares outstanding (in shares) at Sep. 30, 2020 0                                                                                  
Balance at beginning of period at Dec. 31, 2019 $ (18,295)   $ 171,321 $ (189,616) $ (650) $ (18,945)       $ 3   $ 3 $ 0 $ 3     $ 0 $ (1) $ 1 $ 0 $ 0 $ (1) $ 1 $ 0   $ 185,501   $ 158,820 $ 26,681 $ 185,501       $ 0 $ 12,500 $ (12,500) $ 0 $ (203,799) $ 0 $ (203,799) $ (650) $ (204,449)
Balance at beginning of period (in shares) at Dec. 31, 2019                   31,074,000   31,074,000 0 31,074,000     0 (72,319,000) 72,319,000 0 0 (83,987,000) 83,987,000 0                   0 (11,500,000) 11,500,000 0          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                                                    
Stock-based compensation 2,101                                                 2,101                                
Issuance of subsidiary preferred stock (Note 16)                 $ 3,247                                               $ 3,247                  
Issuance of common stock upon exercise of stock options 30                                                 30                                
Issuance of common stock upon exercise of stock options (in shares)                   93,000                                                                
Issuance of common stock upon vesting of restricted stock awards (in shares)                   2,143,000                                                                
Issuance of common stock in connection with acquisition (in shares)                   55,000                                                                
Stock issued during period (in shares)                                                 999,000                                  
Net loss (9,145)                                                                         (9,145)        
Balance at end of period at Sep. 30, 2020 (22,712)                 $ 3             $ 0       $ 0         190,879               $ 0       (213,594)        
Balance at end of period (in shares) at Sep. 30, 2020                   34,364,000             0       0                         0                
Beginning balance, Carrying amount at Dec. 31, 2020 $ 0   $ (174,568) $ 174,568                                                                            
Beginning balance, Shares outstanding (in shares) at Dec. 31, 2020 0   (79,055,000) 79,055,000                                                                            
Ending balance, Carrying amount at Sep. 30, 2021 $ 0                                                                                  
Ending balance, Shares outstanding (in shares) at Sep. 30, 2021 0                                                                                  
Balance at beginning of period at Dec. 31, 2020 $ (32,813)   $ 174,568 $ (207,381)           $ 3   $ 3 $ 0       $ 0 $ (1) $ 1   $ 0 $ (1) $ 1     191,168   $ 162,067 $ 29,101         $ 0 $ 12,500 $ (12,500)   (223,984) $ 0 $ (223,984)    
Balance at beginning of period (in shares) at Dec. 31, 2020 34,692,000                 34,692,000   34,692,000 0       0 (101,022,000) 101,022,000   0 (83,987,000) 83,987,000                     0 (11,500,000) 11,500,000            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                                                    
Stock-based compensation $ 29,265                                                 29,265                                
Issuance of common stock due to Bridge Notes 106,353                 $ 2                               106,351                                
Issuance of common stock due to Bridge Notes (in shares)                   20,343,000                                                                
Issuance of common stock upon exercise of stock options $ 100                                                 100                                
Issuance of common stock upon exercise of stock options (in shares) 969,000                 968,000                                                                
Issuance of common stock upon vesting of restricted stock awards (in shares)                   461,000                                                                
Issuance of common stock upon vesting of restricted stock units (in shares)                   102,000                                                                
Issuance of common stock on conversion (in shares)                     7,736,000       3,251,000 11,187,000                                                    
Issuance of common stock on conversion   $ 77,097         $ 2,289 $ 38,329     $ 1         $ 1                     $ 77,096       $ 2,289 $ 38,328                    
Issuance of sponsor earn-out shares $ (17,659)                                                 (17,659)                                
Reverse recapitalization, net (in shares)                   34,584,000                                                                
Reverse recapitalization, net (Note 4) 200,874                 $ 4                               202,152                       (1,282)        
Net loss (251,038)                                                                         (251,038)        
Balance at end of period at Sep. 30, 2021 $ 152,797                 $ 11             $ 0       $ 0         $ 629,090               $ 0       $ (476,304)        
Balance at end of period (in shares) at Sep. 30, 2021 113,324,000                 113,324,000             0       0                         0                
Balance at beginning of period (in shares) at Sep. 08, 2021 31,625,000                                                                                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                                                                    
Reverse recapitalization, net (in shares) 34,584,000                                                                                  
Reverse recapitalization, net (Note 4) $ 200,874                                                                                  
[1] Inclusive of warrants exercised for preferred stock then exchanged into common stock in connection with merger.